NautaDutilh advises Confo Therapeutics on EUR 60 million Series B funding round

NautaDutilh advised Confo Therapeutics on its EUR 60 million Series B funding round to advance innovative therapies.

The funding round was led by new investor Ackermans & van Haaren and included other new investors like Driehaus Capital Management and Quest for Growth. Existing investors such as BioGeneration Ventures and Capricorn Health-tech Fund also continued their support. The additional funding will support early-stage clinical trials for two of their drug programmes and help advance two more programmes towards approval.

“The new funding will help Confo Therapeutics develop new treatments for rare endocrine diseases and obesity, aiming to improve outcomes for patients with these conditions.”

Philippe Remels, Corporate/M&A partner

About Confo Therapeutics
Confo Therapeutics is a clinical-stage biotechnology company committed to identifying and accelerating novel medicines targeting GPCRs (G protein-coupled receptors). The company’s mission is being advanced by a team of highly experienced industry experts with extensive knowledge of the discovery and development of GPCR-directed medicines. Confo Therapeutics is headquartered in Ghent, Belgium.

Press release

Confotherapeutics.com: Confo Therapeutics announces EUR 60M Series B financing to advance a pipeline of novel GPCR-modulating therapies into clinical development

Related articles

NautaDutilh assists Lineage in the acquisition of Luik Natie

NautaDutilh assists Aon in the sale of its personal lines business in the Netherlands to BlackFin

Musings over the summer – How will the CJEU rule in its anticipated Illumina judgment?

NautaDutilh assists UPM Raflatac in acquiring Grafityp

Navigating Dutch employment and pension reforms: five things you need to know

One year of the FSR: the first (in-depth) investigations and the impact on international trade dynamics

NautaDutilh assists ONWARD Medical in obtaining secured debt financing from Runway Growth Capital

NautaDutilh advises Acomo on their acquisition of nuts and dried food business from Caldic

NautaDutilh assists Nyxoah in its USD 52.5 million capital raise

NautaDutilh advises Vastned Retail on intended reverse cross-border merger with Vastned Belgium

Gaike Dalenoord joins London office

NautaDutilh assists YLP and its group on the acquisition by Centralis Group

CSDDD: scope scaled back and heading for the finish line

ONWARD Medical completes accelerated bookbuild offering

NautaDutilh assists NewAmsterdam Pharma with underwritten offering

M&A in the financial sector seminar 2023: key takeaways

NautaDutilh advises the Bellon family on the spin-off of Pluxee from Sodexo and its listing on Euronext Paris

NautaDutilh advises a.s.r. on its sale of Knab to BAWAG

EU Listing Act: simplified rules for stock exchange listings, especially for SMEs

ESG and capital markets transactions: five things you need to know

CSRD: A second step towards implementation in the Netherlands and change of scope

Benelux Competition Law in 2024: five things you need to know

Online incorporation of a private limited company

Cross-border conversions, mergers and demergers (Mobility Directive)

Quarterly corporate law update - Q3 2023

NautaDutilh assists Telenor Group on the sale of its majority shareholding in Norkring België

NautaDutilh assists Vico Therapeutics International on its EUR 54 million Series B financing round

NautaDutilh Luxembourg assists Pharmathen on its acquisition of CBL Patras

The Foreign Direct Investment Regimes Guide 2024

Five nominations for NautaDutilh at the 2023 Dutch M&A Awards

Maartje Govaert and Inger van Dijkman in Tijdschrift Ondernemingsrecht on transgressive behaviour in the workplace

Life Sciences challenges and opportunities in Europe and the USA: key insights

NautaDutilh assists Colruyt Group on its acquisition of 57 Match and Smatch stores

US clawback rules for US-listed Dutch companies

Update Luxembourg law on business licenses: three key insights

NautaDutilh advises Merus on its USD 173 million follow-on offering of common shares

NautaDutilh advises MCAA on business combination with FC Barcelona’s content creation platform

NautaDutilh assists NIBC on the sale of its equity investment activities

Shareholder Activism & Engagement Guide 2023

Luxembourg parliament adopts long-awaited reform on insolvency laws

The law on the use of digital tools and processes in company law in force in Luxembourg

NautaDutilh assists founding shareholders of Route Mobile in selling majority stake to Proximus

Update on corporate law - Q2 2023

Temporary Transparency of Expedited Liquidation Act

Pay Transparency Directive: equal pay for men and women

NautaDutilh assists Wallonie Entreprendre and Noshaq with the sale of part of their stake in Odoo

CSRD update: draft reporting requirements (ESRS) published

The law on the use of digital tools and processes in company law

Luxembourg: introduction of national FDI screening mechanism

The Dutch Vifo Act: five things you need to know

NautaDutilh advises FEMSA on the full divestment of its stake in Heineken

NautaDutilh advises Vivoryon Therapeutics in its EUR 25 million private placement

NautaDutilh contributes to Beaumont Capital Markets' review 'International Insolvency & Restructuring'

NautaDutilh assists Technip Energies on green hydrogen joint venture with John Cockerill

NautaDutilh assists Léon Grosse on the acquisition of Willemen Construction

NautaDutilh contributes to the Legal 500 M&A Guide

NautaDutilh assists Bluestar Alliance in Scotch & Soda acquisition

NautaDutilh advises the shareholders of SUAZIO on the sale of their shares to NAMSA

EU Foreign Subsidies Regulation (FSR): five things you need to know

New Whistleblower Protection Act: stricter requirements for employers

Benelux Competition Law in 2023: five things you need to know

NautaDutilh advises FEMSA on the partial divestment of its stake in Heineken

NautaDutilh assisted FairPhone on its EUR 49 million investment round

NautaDutilh coaches Belgian TechShare participants

NautaDutilh assists the Joint Bookrunners with Care Property Invest's EUR 110 million rights issue

NautaDutilh advises on the sale of a majority stake in S-Biomedic to Beiersdorf

Final CSRD mandates more sustainability reporting

Update of the Dutch Corporate Governance Code finalised

GDPR & AML: no longer public access to UBO data without legitimate interest

No longer public access to UBO data without legitimate interest

Two deals on which NautaDutilh advised on win at the Belgian M&A Awards 2022

NautaDutilh involved in three deals shortlisted for the Belgian M&A Awards

The act of 28 October 2022 on the procedure of administrative dissolution without liquidation comes into effect on 1st February 2023

Consultation on new rules for partnerships

NautaDutilh advises a.s.r. on their accelerated bookbuild offering, raising EUR 593.6 million

NautaDutilh advises a.s.r. on its proposed business combination with Aegon Nederland

NautaDutilh assists the shareholders on the sale of Cloostermans to Amazon

NautaDutilh contributes to Mergers & Acquisitions Guide by Legal 500

NautaDutilh assists private equity firm Astorg with its acquisition of IPCOM